chrX-30854952-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_152787.5(TAB3):c.713G>A(p.Ser238Asn) variant causes a missense change. The variant allele was found at a frequency of 0.00011 in 1,206,866 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 34 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000072 ( 0 hom., 1 hem., cov: 22)
Exomes 𝑓: 0.00011 ( 0 hom. 33 hem. )
Consequence
TAB3
NM_152787.5 missense
NM_152787.5 missense
Scores
4
13
Clinical Significance
Conservation
PhyloP100: 4.50
Genes affected
TAB3 (HGNC:30681): (TGF-beta activated kinase 1 (MAP3K7) binding protein 3) The product of this gene functions in the NF-kappaB signal transduction pathway. The encoded protein, and the similar and functionally redundant protein MAP3K7IP2/TAB2, forms a ternary complex with the protein kinase MAP3K7/TAK1 and either TRAF2 or TRAF6 in response to stimulation with the pro-inflammatory cytokines TNF or IL-1. Subsequent MAP3K7/TAK1 kinase activity triggers a signaling cascade leading to activation of the NF-kappaB transcription factor. The human genome contains a related pseudogene. Alternatively spliced transcript variants have been described, but their biological validity has not been determined. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.014193237).
BS2
High Hemizygotes in GnomAdExome4 at 33 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TAB3 | NM_152787.5 | c.713G>A | p.Ser238Asn | missense_variant | 6/11 | ENST00000288422.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TAB3 | ENST00000288422.4 | c.713G>A | p.Ser238Asn | missense_variant | 6/11 | 5 | NM_152787.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000717 AC: 8AN: 111600Hom.: 0 Cov.: 22 AF XY: 0.0000296 AC XY: 1AN XY: 33754
GnomAD3 genomes
AF:
AC:
8
AN:
111600
Hom.:
Cov.:
22
AF XY:
AC XY:
1
AN XY:
33754
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000316 AC: 55AN: 173908Hom.: 0 AF XY: 0.000285 AC XY: 17AN XY: 59554
GnomAD3 exomes
AF:
AC:
55
AN:
173908
Hom.:
AF XY:
AC XY:
17
AN XY:
59554
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000114 AC: 125AN: 1095266Hom.: 0 Cov.: 31 AF XY: 0.0000914 AC XY: 33AN XY: 360882
GnomAD4 exome
AF:
AC:
125
AN:
1095266
Hom.:
Cov.:
31
AF XY:
AC XY:
33
AN XY:
360882
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000717 AC: 8AN: 111600Hom.: 0 Cov.: 22 AF XY: 0.0000296 AC XY: 1AN XY: 33754
GnomAD4 genome
AF:
AC:
8
AN:
111600
Hom.:
Cov.:
22
AF XY:
AC XY:
1
AN XY:
33754
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
17
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 20, 2023 | The c.713G>A (p.S238N) alteration is located in exon 6 (coding exon 2) of the TAB3 gene. This alteration results from a G to A substitution at nucleotide position 713, causing the serine (S) at amino acid position 238 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;.
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;T;T
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;N;N
MutationTaster
Benign
N;N;N;N
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Benign
T;T;T
Sift4G
Benign
T;T;T
Polyphen
B;B;B
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at